ERCC1
ERCC1 is a vital component of the DNA repair machinery, forming a structure-specific endonuclease with its partner XPF. This complex acts as molecular scissors to perform the critical 5’ incision during Nucleotide Excision Repair (NER) and is essential for the resolution of toxic interstrand crosslinks. Deficiency in ERCC1 leads to severe progeroid syndromes and accelerated organ aging, while its high expression in tumors is a primary driver of resistance to platinum-based chemotherapies.
Key Takeaways
- •ERCC1 is a fundamental component of the Nucleotide Excision Repair (NER) pathway, essential for fixing bulky DNA lesions.
- •It forms an obligate heterodimer with XPF, acting as "molecular scissors" that cut DNA on the 5’ side of a lesion.
- •ERCC1 is also critical for the repair of interstrand crosslinks (ICLs), among the most toxic types of DNA damage.
- •Levels of ERCC1 are a major predictor of resistance to platinum-based chemotherapy in various cancers.
Basic Information
- Gene Symbol
- ERCC1
- Full Name
- ERCC Excision Repair 1
- Also Known As
- COFS4UV20
- Location
- 19q13.32
- Protein Type
- Endonuclease Subunit
- Protein Family
- ERCC1 Family
Related Isoforms
Key SNPs
Common synonymous variant; extensively studied as a biomarker for response to platinum-based chemotherapy.
Polymorphism that may influence ERCC1 splicing or expression levels in specific tissues.
Studied in the context of individual variation in DNA repair capacity and cancer risk.
A common missense variant investigated for its impact on Nucleotide Excision Repair (NER) efficiency.
Frequently used as a tag SNP in large-scale genetic association studies of longevity.
Variant in the regulatory tail that may affect mRNA stability and protein abundance.
Overview
ERCC1 (ERCC Excision Repair 1) is an essential component of the cellular DNA repair machinery, specifically within the Nucleotide Excision Repair (NER) pathway. It acts as a structure-specific endonuclease subunit, working in an obligate heterodimer with its partner protein, XPF.
Together, the ERCC1-XPF complex functions as "molecular scissors," identifying distorted DNA structures and performing a precise cut on the 5’ side of the lesion. This is a critical step in the repair of bulky DNA adducts caused by UV light and various chemical mutagens, as well as the resolution of toxic interstrand crosslinks.
Conceptual Model
A simplified mental model for the pathway:
Core Health Impacts
- • Skin protection: Protects against skin cancer by repairing UV-induced damage
- • Systemic longevity: Prevents systemic progeria (premature aging) through genomic maintenance
- • Crosslink resolution: Essential for the resolution of interstrand crosslinks (ICLs)
- • Stem cell support: Supports long-term stem cell function in the liver and bone marrow
- • Drug sensitivity: Determines the sensitivity or resistance of tumors to platinum drugs
Protein Domains
N-terminal Domain
Contains the DNA-binding surface that recognizes the junction between single-stranded and double-stranded DNA.
Central Domain
Provides structural stability and facilitates interactions with other NER proteins like XPA.
HhH2 Domain
The C-terminal Helix-hairpin-Helix domain that mediates the high-affinity heterodimerization with XPF.
Upstream Regulators
XPA Activator
The primary damage-verification protein that recruits the ERCC1-XPF complex to the site of the lesion.
XPF (ERCC4) Activator
The obligate catalytic partner; ERCC1 is unstable and is rapidly degraded without its interaction with XPF.
SLX4 Activator
A master scaffold protein that recruits ERCC1-XPF to interstrand crosslinks and other complex DNA structures.
RPA Activator
Coats single-stranded DNA and helps orient the ERCC1-XPF complex for precise endonucleolytic cleavage.
DNA Lesions Activator
Bulky adducts (from UV or chemicals) trigger the NER pathway, leading to ERCC1 mobilization.
Downstream Targets
DNA Backbone Inhibits
The primary substrate; ERCC1-XPF performs the 5'-incision relative to the DNA lesion.
FANCD2 Activates
Works alongside the Fanconi Anemia pathway to facilitate the resolution of toxic interstrand crosslinks.
Telomeric DNA Modulates
Involved in the processing and maintenance of telomeric structures, particularly under stress.
RNA Polymerase II Modulates
ERCC1 helps resolve stalled transcription complexes, preventing chronic transcriptional stress.
XPG Activates
Coordinates with XPG (which performs the 3'-cut) to ensure the complete excision of the damaged DNA fragment.
Role in Aging
ERCC1 is one of the most critical genes for preventing accelerated aging. Its role in Nucleotide Excision Repair (NER) is essential for handling transcription-blocking lesions, which are a major driver of the cellular and systemic decline seen in aging.
Transcriptional Stress
Unrepaired NER lesions block RNA polymerase II, leading to a global reduction in transcription that mimics the functional decline of old age.
Crosslink Resolution
Interstrand crosslinks are among the most toxic age-related lesions. ERCC1 is essential for "unhooking" these crosslinks to allow replication restart.
Stem Cell Exhaustion
ERCC1 deficiency leads to rapid stem cell depletion in the liver, bone marrow, and other tissues, causing premature organ failure.
Adaptive Response
ERCC1-deficient models activate a highly conserved survival response, shifting resources from growth (GH/IGF-1) to cellular maintenance and defense.
Neurodegeneration
Accumulated bulky DNA damage in non-dividing neurons is linked to the cognitive decline seen in several ERCC1-related syndromes.
Progeroid Logic
ERCC1-deficient mice live only a fraction of their normal lifespan, providing a powerful tool for studying the fundamental mechanisms of human aging.
Disorders & Diseases
Xeroderma Pigmentosum (Group F)
A rare disorder characterized by extreme sensitivity to UV light, excessive skin pigmentation, and a massively increased risk of skin cancer.
Cockayne Syndrome
A severe progeroid disorder featuring growth failure, microcephaly, and neurodegeneration, caused by defects in the transcription-coupled NER pathway.
COFS Syndrome
Cerebro-oculo-facio-skeletal syndrome represents the most severe end of the ERCC1-deficiency spectrum, often fatal in early childhood.
Platinum Resistance
High expression of ERCC1 in tumors (like lung and gastric cancer) is a well-established driver of resistance to cisplatin and carboplatin therapy.
Interventions
Supplements
Support general cellular health and may reduce the endogenous "load" of DNA damage requiring repair.
Known to influence the expression of several NER genes and support healthy cell cycle checkpoints.
NER is an energy-intensive process; adequate NAD+ levels support the overall cellular repair capacity.
Induces Nrf2-mediated defenses that can cross-talk with and support DNA repair efficiency.
Lifestyle
The single most important intervention for NER-deficient systems; prevents the formation of bulky pyrimidine dimers.
Cigarette smoke contains numerous bulky DNA adducts that place high demand on the ERCC1-XPF complex.
Provides the diverse micronutrients (Zinc, Magnesium) required as cofactors for repair enzymes.
Reduces intake of polycyclic aromatic hydrocarbons, which are typically repaired by the NER pathway.
Medicines
Cisplatin and carboplatin create DNA crosslinks; ERCC1 levels in tumors are a major predictor of drug resistance.
Research-stage compounds being studied to sensitize resistant tumors to DNA-damaging chemotherapy.
Topical agents that block the specific wavelengths of light that create the lesions ERCC1 must repair.
Lab Tests & Biomarkers
Genetic Testing
Sequencing used to diagnose XP-F or severe progeroid syndromes.
A common variant often included in research panels for chemotherapy response.
Expression Markers
Clinical assay to measure protein levels in tumor biopsies.
RT-qPCR analysis of ERCC1 transcripts to predict repair capacity.
Functional Markers
Unscheduled DNA Synthesis; the gold-standard test for NER proficiency.
Cellular sensitivity to MMC or Cisplatin as a readout of ERCC1-XPF activity.
Hormonal Interactions
Thyroid Hormone Metabolic Regulator
ERCC1 deficiency models often show altered thyroid signaling as an adaptive "survival response" to chronic damage.
Growth Hormone Growth Driver
GH signaling is frequently suppressed in ERCC1-deficient progeria to prioritize maintenance over growth.
IGF-1 Maintenance Influencer
Low IGF-1 is a hallmark of the adaptive response to global DNA repair defects, helping to delay senescence.
Cortisol Stress Modulator
Chronic stress can impair the efficiency of DNA repair pathways, potentially exacerbating the effects of ERCC1 decline.
Deep Dive
Network Diagrams
The Nucleotide Excision Repair (NER) Cycle
Interstrand Crosslink (ICL) Unhooking
The Molecular Scissors: How ERCC1-XPF Cuts DNA
The ERCC1-XPF complex is a structure-specific endonuclease, meaning it doesn’t recognize a specific sequence of DNA, but rather a specific shape. Its job is to identify the junction where double-stranded DNA opens up into single-stranded DNA—a hallmark of a bulky lesion.
- The incision: Once recruited by XPA and oriented by RPA, the complex positions its catalytic site (on the XPF subunit) exactly five nucleotides away from the lesion on the 5’ side. This incision, paired with a 3’ cut by the XPG enzyme, releases a damaged 24-32 nucleotide fragment, allowing high-fidelity polymerases to fill the gap.
Resolution of Toxic Interstrand Crosslinks
Interstrand crosslinks (ICLs) are covalent bonds that link both strands of the DNA double helix together, preventing them from opening for replication or transcription. These are among the most lethal DNA lesions.
- The “Unhooking” Step: When a replication fork hits an ICL, it stalls. The SLX4 scaffold recruits ERCC1-XPF to the site. The complex performs dual incisions on one strand, “unhooking” the crosslink. This allows the other strand to be repaired by the Fanconi Anemia and homologous recombination pathways, essentially turning a catastrophic block into a manageable repair task.
Progeria and the Survival Response
The most striking evidence for ERCC1’s role in aging comes from the systemic response to its loss. ERCC1-deficient cells accumulate damage that blocks transcription, triggering a massive cellular stress response.
- Systemic Trade-off: Intriguingly, this damage doesn’t just kill cells; it causes the entire organism to shift its metabolism. Growth hormone and IGF-1 signaling are downregulated, and the body shifts into a “maintenance mode” that mimics the state seen in long-lived caloric-restricted animals. This suggests that the systemic aging phenotype is partly an adaptive, but ultimately failing, attempt by the organism to survive chronic genomic instability.
Relevant Research Papers
Links go to PubMed (abstracts are public); some papers also offer free full text via PMC or the publisher.
The foundational study that defined the interaction between ERCC1 and XPF and its role in NER.
Demonstrated that total loss of ERCC1 leads to severe growth failure and premature death due to repair failure.
Established the link between ERCC1-XPF defects and human progeroid syndromes, connecting NER to aging biology.
A landmark clinical study identifying ERCC1 as a critical biomarker for chemotherapy response in oncology.
Revealed how ERCC1-XPF is recruited to complex lesions like interstrand crosslinks by the SLX4 scaffold.
Detailed the structural interaction between ERCC1 and XPF, showing how they form a functional endonuclease.